Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Pediatr Infect Dis J. 2013 May;32(5):489–494. doi: 10.1097/INF.0b013e31827e84ba

Table 3.

Predicators of non-adherence (MR adherence <85% to any drug) by regimen

Number (%)subjects LPV/r Regimens Ritonavir Regimens

MR <85% (N=636) MR <85% (N=470)

N = 269 OR CI p-value OR CI p-value
Age <12 months at enrollment 175 (65%) 1.01 0.61–1.67 0.96 0.85 0.47–1.53 0.59
Sex (female) 128 (48%) 1.23 0.74–2.04 0.42 0.98 0.55–1.73 0.94
Treatment naïve at enrollment 210 (78%) 0.97 0.53–1.77 0.92 1.11 0.51–2.39 0.79
Pre-treatment CD4 percentage <10% 41 (16%) 1.11 0.51–2.41 0.80 0.99 0.51–1.95 0.99
Pre-treatment Viral load >100,000 210 (89%) 0.81 0.47–1.39 0.45 1.24 0.66–2.33 0.50
Pre-treatment WHO stage 3 or 4 208 (77%) 1.36 0.73–2.55 0.34 1.59 0.74–3.46 0.24
Mother disclosed HIV status 233 (88%) 0.78 0.34–1.77 0.55 0.58 0.29–1.19 0.14
Mother on ART at enrollment 35 (13%) 0.65 0.32–1.32 0.23 0.30 .07–1.33 0.11
Mother (PCG) paid job 70 (26%) 1.19 0.67–2.11 0.56 1.77 0.98–3.21 0.06
Mother completed secondary education 95 (35%) 0.48 0.27–0.88 .02 1.08 0.61–1.89 0.80
Adults in home who don’t know child’s status 97 (36%) 0.89 0.53–1.49 0.66 1.19 0.67–2.12 0.55
Someone other than mother mainly cares for child 24 (13%) 1.16 0.55–2.46 0.70 1.44 0.70–2.99 0.33
Tap in home 117 (44%) 0.82 0.49–1.36 0.44 1.21 0.58–1.81 0.92
Electricity 224 (84%) 0.38 0.22–0.66 0.00 0.86 0.39–1.91 0.71
TV in home 208 (78%) 0.47 0.27–0.81 0.01 0.99 0.44–2.20 0.97
Fridge in home 168 (63%) 0.44 0.27–0.73 0.00 0.89 0.49–1.61 0.69

Number (%)visits
Someone other than mother gives medication 366/1200 (31%) 1.23 0.73–2.08 0.43 1.11 0.62–2.00 0.73

Univariable logistic GEE model used to account for repeat measurements per child